Floatz logo

38 assets in Indolent B-Cell Non-Hodgkin Lymphoma

Therapeutic assets addressing Indolent B-Cell Non-Hodgkin Lymphoma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Cyclophosphamide
Indolent B-Cell Non-Hodgkin Lymphoma
Institute of Hematology & Blood Diseases Hospital, ChinaP2BB (68)
Fludarabine
Indolent B-Cell Non-Hodgkin Lymphoma
Institute of Hematology & Blood Diseases Hospital, ChinaP3BB (68)
Rituximab
Indolent B-Cell Non-Hodgkin Lymphoma
Fox Chase Cancer CenterP3BB (67)
Ibrutinib
Indolent B-Cell Non-Hodgkin Lymphoma
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityP3BB (65)
Acalabrutinib
Indolent B-Cell Non-Hodgkin Lymphoma
Emory UniversityP2BB (64)
Lenalidomide
Indolent B-Cell Non-Hodgkin Lymphoma
Antengene CorporationP2BB (64)
Polatuzumab Vedotin
Indolent B-Cell Non-Hodgkin Lymphoma
University of WashingtonP2BB (64)
Adriamycin
Indolent B-Cell Non-Hodgkin Lymphoma
Fate TherapeuticsP2B (63)
Etoposide
Indolent B-Cell Non-Hodgkin Lymphoma
David Bond, MDP2B (63)
Obinutuzumab
Indolent B-Cell Non-Hodgkin Lymphoma
Reid Merryman, MDP2B (63)
Prednisone
Indolent B-Cell Non-Hodgkin Lymphoma
Fate TherapeuticsP2B (63)
Bendamustine
Indolent B-Cell Non-Hodgkin Lymphoma
Fox Chase Cancer CenterP3B (62)
Nivolumab
Indolent B-Cell Non-Hodgkin Lymphoma
City of Hope Medical CenterP2B (58)
Vincristine Sulfate
Indolent B-Cell Non-Hodgkin Lymphoma
Mayo ClinicP2B (58)
ibi376
Indolent B-Cell Non-Hodgkin Lymphoma
Chinese PLA General HospitalP2B (57)
Mosunetuzumab
Indolent B-Cell Non-Hodgkin Lymphoma
University of WashingtonP2B (57)
Jcar-017 Cd19-Specific Chimeric Antigen Receptor
Indolent B-Cell Non-Hodgkin Lymphoma
Fred Hutchinson Cancer CenterP1/2CCC (54)
Boclatixafortide
Indolent B-Cell Non-Hodgkin Lymphoma
Koo Foundation Sun Yat-Sen Cancer CenterP2CCC (53)
Immunoglobulin G1 (149-Glutamic Acid,215-Glutamic Acid,461-Alanine,462-Alanine,556-Glycine,581-Cysteine,593-Tryptophan), Anti-(Human Cd20 Antigen) (Human-Mus Musculus Monoclonal Rg6026 Vh-Ch1 Fragment) Fusion Protein With Peptide (Synthetic 10-Amino Acid Linker) Fusion Protein With Immunoglobulin Anti-(Human Cd3 Antigen .Epsilon.-Chain) (Human-Mus Musculus Monoclonal Rg6026 Heavy Chain Vl(.Lambda.)-Ch1-Ch2-Ch3), (222->219''')-Disulfide With Immunoglobulin Anti-(Human Cd20 Antigen) (Human-Mus Musculus Monoclonal Rg6026 .Kappa.-Chain (128-Arginine,129-Lysine)) And (447->232'')-Disulfide With Immunoglobulin Anti-(Human Cd3 Antigen .Epsilon.-Chain) (Human-Mus Musculus Monoclonal Rg6026 Light Chain Vh-Cl(.Kappa.)), (453->228'), (456->231'), (581->351')-Tris(Disulfide) With Immunoglobulin G1 (149-Glutamic Acid,215-Glutamic Acid,236-Alanine,237-Alanine,331-Glycine,351-Cysteine,368-Serine,370-Alanine,409-Valine) Anti-(Human Cd20 Antigen) (Human-Mus Musculus Monoclonal Rg6026 .Gamma.1-Chain) Disulfide With Human-Mus Musculus Monoclonal Rg6026 .Kappa.-Chain (128-Arginine,129-Lysine)
Indolent B-Cell Non-Hodgkin Lymphoma
Reid Merryman, MDP2CCC (53)
Epcoritamab
Indolent B-Cell Non-Hodgkin Lymphoma
GenmabP1/2CCC (48)
Interleukin 18 (Recombinant Human Mutein Clone St-067)
Indolent B-Cell Non-Hodgkin Lymphoma
Fred Hutchinson Cancer CenterP1/2CCC (48)
Anti-Cd32B Monoclonal Antibody Bi-1206
Indolent B-Cell Non-Hodgkin Lymphoma
BioInvent International ABP1/2CC (47)
CD47/SIRPA-BLOCKING AGENT ALX148
Indolent B-Cell Non-Hodgkin Lymphoma
M.D. Anderson Cancer CenterP1/2CC (47)
cy-219 car-t
Indolent B-Cell Non-Hodgkin Lymphoma
Institute of Hematology & Blood Diseases Hospital, ChinaP1CC (43)
Stk-009
Indolent B-Cell Non-Hodgkin Lymphoma
SynthekineP1CC (43)
Syncar-001
Indolent B-Cell Non-Hodgkin Lymphoma
SynthekineP1CC (43)
Synkir-310
Indolent B-Cell Non-Hodgkin Lymphoma
Verismo TherapeuticsP1CC (43)
(+)-Vincristine
Indolent B-Cell Non-Hodgkin Lymphoma
Fate TherapeuticsP1CC (43)
xl114
Indolent B-Cell Non-Hodgkin Lymphoma
ExelixisP1CC (43)
Zandelisib
Indolent B-Cell Non-Hodgkin Lymphoma
Kyowa Kirin Co., Ltd.P2CC (43)
Car.K.28
Indolent B-Cell Non-Hodgkin Lymphoma
UNC Lineberger Comprehensive Cancer CenterP1CC (41)
Cnty-101
Indolent B-Cell Non-Hodgkin Lymphoma
Century Therapeutics, Inc.P1CC (41)
Copanlisib
Indolent B-Cell Non-Hodgkin Lymphoma
BayerP1CC (41)
Parsaclisib
Indolent B-Cell Non-Hodgkin Lymphoma
Mayo ClinicP1CC (41)
Pegfilgrastim
Indolent B-Cell Non-Hodgkin Lymphoma
Mayo ClinicP1CC (41)
Tak-243
Indolent B-Cell Non-Hodgkin Lymphoma
National Cancer Institute (NCI)P1CC (41)
ft596
Indolent B-Cell Non-Hodgkin Lymphoma
Fate TherapeuticsP1CC (40)
Atg-010
Indolent B-Cell Non-Hodgkin Lymphoma
Antengene CorporationP1/2C (39)